Belçika - Almanca - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - sitagliptin - filmtablette - 25 mg - sitagliptin 25 mg - sitagliptin

Belçika - Almanca - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - sitagliptin - filmtablette - 50 mg - sitagliptin 50 mg - sitagliptin

Belçika - Almanca - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - sitagliptin - filmtablette - 100 mg - sitagliptin 100 mg - sitagliptin

Avrupa Birliği - Almanca - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

akciju sabiedriba "grindeks" beiname: joint stock company "grindeks" (8074446) - filmtablette - 50 mg/1000 mg

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

akciju sabiedriba "grindeks" beiname: joint stock company "grindeks" (8074446) - filmtablette - 50 mg/850 mg

Avusturya - Almanca - AGES (Agentur für Gesundheit und Ernährungssicherheit)

adamed pharma s.a. - metformin hydrochlorid; sitagliptin hydrochlorid monohydrat -

Avusturya - Almanca - AGES (Agentur für Gesundheit und Ernährungssicherheit)

adamed pharma s.a. - metformin hydrochlorid; sitagliptin hydrochlorid monohydrat -

Avusturya - Almanca - AGES (Agentur für Gesundheit und Ernährungssicherheit)

adamed pharma s.a. - metformin hydrochlorid; sitagliptin hydrochlorid monohydrat -

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

alfred e. tiefenbacher (gmbh & co. kg) (8016331) - filmtablette - 50/1000 mg